Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-15,555
Closed -$211K 87
2016
Q4
$211K Sell
15,555
-15,950
-51% -$204K 0.11% 83
2016
Q3
$416K Buy
31,505
+4,850
+18% +$72.3K 0.21% 67
2016
Q2
$421K Sell
26,655
-37,715
-59% -$604K 0.19% 70
2016
Q1
$891K Sell
64,370
-1,000
-2% -$11.6K 0.29% 57
2015
Q4
$761K Sell
65,370
-150,225
-70% -$1.98M 0.23% 60
2015
Q3
$2.46M Sell
215,595
-12,743
-6% -$179K 0.59% 42
2015
Q2
$4.62M Sell
228,338
-49,588
-18% -$1.16M 1.03% 32
2015
Q1
$6.03M Sell
277,926
-6,909
-2% -$158K 1.3% 27
2014
Q4
$6.25M Sell
284,835
-27,979
-9% -$763K 1.29% 30
2014
Q3
$10.4M Sell
312,814
-277
-0.1% -$10.2K 2.08% 18
2014
Q2
$12.7M Buy
313,091
+17,586
+6% +$653K 2.48% 14
2014
Q1
$9.87M Buy
+295,505
New +$9.54M 2% 19

Other funds holding VRN

Chelsea Counsel Company's VRN Position: Q1 2017 in Review

Chelsea Counsel Company sold out of Veren (VRN) in Q1 2017, closing a stake of 15,555 shares — an estimated $211K sold.

Chelsea Counsel Company first reported a position in VRN in Q1 2014 and held it in 12 quarters. The position peaked at $12.7M in Q2 2014. 170 funds tracked by Wall St. Rank hold VRN as of Q1 2017.

  • Chelsea Counsel Company reported no remaining Veren position as of Q1 2017 after selling out during the quarter.
  • Chelsea Counsel Company sold 15,555 Veren shares in Q1 2017, an estimated $211K.
  • Chelsea Counsel Company first reported a position in Veren in Q1 2014 and held it in 12 quarters.
  • Chelsea Counsel Company's Veren position peaked at $12.7M in Q2 2014.
  • 170 funds tracked by Wall St. Rank held Veren as of Q1 2017.

Based on Chelsea Counsel Company's 13F filing for Q1 2017, filed 20 Apr 2017.